EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Circular RNAs in Hepatocellular Carcinoma: Biogenesis, Detection, Functional Mechanisms, and Translational Evidence

Benlei Xu, Jingyi Wei, Wei Li, Yingchu Huang, Yong Ye, Jinru Li, Lingjuan Mai, Yichang Wen, Yinai Zhong, Ruili Wang, Jiyong Peng, Dongbin Huang und 2 weitere

Journal of Hepatocellular Carcinoma · 2026-11 · Volume 13 · 1-18

DOI: 10.2147/jhc.s628087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-11. Verfasst von Benlei Xu und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circular RNAs (circRNAs) have been implicated in hepatocellular carcinoma (HCC) through microRNA-associated regulation, protein interactions, transcriptional control, and production of functional peptides. However, mechanistic activity does not establish clinical usefulness. This critical narrative review examines circRNA biogenesis, synthesis, and detection, then evaluates how selected HCC findings support proposed diagnostic and therapeutic applications. It distinguishes general RNA technologies from HCC-specific evidence and separates cell and animal experiments from human clinical validation. Representative studies are compared by circular RNA identity, molecular mechanism, experimental model, cohort design, and independent validation. The diagnostic literature includes a plasma circRNA panel evaluated in independent HBV-related cohorts, but prospective benefit beyond established surveillance remains unproven. Other candidates show prognostic or treatment-associated signals that require validation in clinically relevant populations, including patients with cirrhosis. CircRNA-SORE, circIPO11, and circPETH-147aa provide testable preclinical therapeutic hypotheses, while engineered circRNA vaccines remain supported by animal studies in the reports examined. Major priorities include reproducible junction-specific assays, confirmation of endogenous mechanisms, etiological and stage-specific validation, selective delivery, and assessment of pharmacokinetics, immunogenicity, and manufacturing consistency. CircRNAs warrant further investigation in HCC, but development should be guided by the intended clinical decision and the strength of the supporting evidence rather than by molecular association alone. Keywords: hepatocellular carcinoma, circular RNAs, biogenesis, biomarkers, molecular mechanisms, translational research

Zitieren

APA

Xu, B., Wei, J., Li, W., Huang, Y., Ye, Y., Li, J., Mai, L., Wen, Y., Zhong, Y., Wang, R., Peng, J., Huang, D., Cao, K., & Ran, G. (2026). Circular RNAs in Hepatocellular Carcinoma: Biogenesis, Detection, Functional Mechanisms, and Translational Evidence. Journal of Hepatocellular Carcinoma, Volume 13, 1-18. https://doi.org/10.2147/jhc.s628087

Vancouver

Xu B, Wei J, Li W, Huang Y, Ye Y, Li J, et al. Circular RNAs in Hepatocellular Carcinoma: Biogenesis, Detection, Functional Mechanisms, and Translational Evidence. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-18. doi:10.2147/jhc.s628087

BibTeX
@article{Xu2026,
  author = {Xu, Benlei and Wei, Jingyi and Li, Wei and Huang, Yingchu and Ye, Yong and Li, Jinru and Mai, Lingjuan and Wen, Yichang and Zhong, Yinai and Wang, Ruili and Peng, Jiyong and Huang, Dongbin and Cao, Keshen and Ran, Gai},
  title = {Circular RNAs in Hepatocellular Carcinoma: Biogenesis, Detection, Functional Mechanisms, and Translational Evidence},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--18},
  doi = {10.2147/jhc.s628087}
}
Kostenlos starten →